FRIDAY, Feb. 1 (HealthDay News) -- During pregnancy, asthmatic women
should continue to use their asthma medication in the lowest dose possible to
manage symptoms.
So recommends a new Practice Bulletin just released by the American College of
Obstetricians and Gynecologists (ACOG).
The bulletin says women with moderate or severe asthma should also be monitored
throughout pregnancy for fetal growth restriction and signs of possible preterm
birth.
During pregnancy, asthma attacks may deprive the fetus of oxygen and may be
associated with premature birth, growth restriction and other fetal
complications, as well as illness and death in women, the ACOG said.
The new recommendations are based on a review of existing studies and support
the position of the U.S. National Asthma Education Prevention Program that "it
is safer for pregnant women with asthma to be treated with asthma medications
than it is for them to have asthma symptoms and exacerbations."
"Previously, there was limited guidance regarding the management of asthma
during pregnancy," Dr. Andrew J. Satin, chairman of the ACOG's Committee on
Practice Bulletins-Obstetrics, said in a prepared statement. "With the growing
number of asthmatics in the U.S., it became a priority to formalize
recommendations for ob-gyns, who will likely see an increasing number of
asthmatic patients."
"Research consistently shows that women with well-controlled asthma can have
healthy pregnancies with excellent maternal and perinatal outcomes," Dr.
Mitchell P. Dombrowski, an ACOG Fellow who contributed to the new Practice
Bulletin, said in a prepared statement. "The ultimate goal of controlling asthma
during pregnancy is to ensure that the fetus continues to get adequate oxygen by
preventing asthma attacks."
The bulletin is published in the February issue of Obstetrics and amp;
Gynecology.
